Transdermal Patch Market

Transdermal Patch is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.Transdermal Patches include fentanyl transdermal patch, nicotine transdermal patch, buprenorphine transdermal patch, clonidine transdermal patch, oxybutynin transdermal patch, estradiol transdermal patch, nitroglycerin transdermal patch and many others.

Transdermal Patch Market contains market size and forecasts of Transdermal Patch in global, including the following market information:

Global Transdermal Patch Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global Transdermal Patch Market Sales, 2017-2022, 2023-2028, (M Pcs)

Global top five Transdermal Patch companies in 2021 (%)

The global Transdermal Patch market was valued at 6989.7 million in 2021 and is projected to reach US$ 8859.9 million by 2028, at a CAGR of 3.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Methyl Salicylate-based Patch Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Transdermal Patch include Hisamitsu Pharmaceutical, Johnson & Johnson, Novartis, UCB Pharma, Mylan, Teva Pharmaceutical, Nitto Denko, Gr?nenthal and IBSA Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Transdermal Patch manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Transdermal Patch Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Transdermal Patch Market Segment Percentages, by Type, 2021 (%)

Methyl Salicylate-based Patch

Rivastigmine Transdermal Patch

Fentanyl Transdermal Patch

Lidocaine Patch

Diclofenac Patch

Nicotine Transdermal Patch

Others

Global Transdermal Patch Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Transdermal Patch Market Segment Percentages, by Application, 2021 (%)

Rx Channel

OTC Channel

Global Transdermal Patch Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Pcs)

Global Transdermal Patch Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Transdermal Patch revenues in global market, 2017-2022 (Estimated), ($ millions)

Key companies Transdermal Patch revenues share in global market, 2021 (%)

Key companies Transdermal Patch sales in global market, 2017-2022 (Estimated), (M Pcs)

Key companies Transdermal Patch sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Hisamitsu Pharmaceutical

Johnson & Johnson

Novartis

UCB Pharma

Mylan

Teva Pharmaceutical

Nitto Denko

Gr?nenthal

IBSA Group

GSK

Luye Pharma Group

Pfizer

Chattem

Dr Reddy?s Laboratories

Bayer

Mundipharma

Endo International

Beijing Tide Pharmaceutical